CNI (calcineurin Inhibitor ) IS regimen
Showing 1 - 25 of >10,000
Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)
Recruiting
- Renal Allograft Recipients
- Belatacept
- +5 more
-
Birmingham, Alabama
- +14 more
Oct 24, 2022
Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient) Trial in San Francisco, Chicago,
Completed
- Liver Transplant Recipient
- Living Donor (of the Respective Liver Transplant Recipient)
- darTregs
- +4 more
-
San Francisco, California
- +2 more
Jan 21, 2021
Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,
Completed
- Renal Insufficiency
- Kidney Transplantation
- tacrolimus OD, mycophenolic acid, prednisolone
-
Amsterdam, Netherlands
- +2 more
Dec 20, 2021
Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)
Terminated
- Hematologic Malignancies
- Itacitinib
- Calcineurin inhibitor
-
Aurora, Colorado
- +16 more
Apr 29, 2022
Kidney Transplant Trial in Canada, United States (Abatacept, Standard of Care at US Transplant Centers)
Not yet recruiting
- Kidney Transplant
- Abatacept
- Standard of Care at US Transplant Centers
-
Birmingham, Alabama
- +19 more
Jun 20, 2023
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
Primary Renal Allograft Trial in Cincinnati (mycophenolate mofetil, sirolimus)
Completed
- Primary Renal Allograft
- mycophenolate mofetil
- sirolimus
-
Cincinnati, Ohio
- +1 more
Jul 8, 2021
Chronic Kidney Failure Trial in Nantes (Belatacept 250 Milligram Intravenous Powder for Solution)
Not yet recruiting
- Chronic Kidney Failure
- Belatacept 250 Milligram Intravenous Powder for Solution
-
Nantes, Loire Atlantique, FranceCHU Nantes
Sep 28, 2022
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Long-term Follow-up of Spare the Nephron (STN) Patients
Completed
- Kidney Transplant
-
Baltimore, MarylandUniversity of Maryland Medicine, Division of Adult Nephrology
Feb 25, 2022
End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet
Completed
- End Stage Renal Disease
- Rejection of Renal Transplant
- Tacrolimus
- Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Chicago, IllinoisNorthwestern University
Jan 12, 2023
CNI Side Effects Trial in Minneapolis (Cyclosporine & Cellcept, Prograf & Cellcept, Low Dose CNI (Cyclosporine or FK) and
Completed
- CNI Side Effects
- Cyclosporine & Cellcept
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 17, 2020
GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)
Recruiting
- GVHD
- Hematologic Neoplasms
- Cyclophosphamide
- +3 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Mar 21, 2022
Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate
Not yet recruiting
- Lung Transplant; Complications
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 6, 2022
GVHD, Malignancy Trial in Canada, United States (Abatacept, )
Active, not recruiting
- Graft vs Host Disease
- Malignancy
- Abatacept
- placebo
-
Los Angeles, California
- +13 more
Jan 9, 2023
Acute Leukemia, Myelodysplasia Trial in United States (Unmanipulated Bone Marrow Graft with Tacrolimus/Methotrexate, Mobilized
Completed
- Acute Leukemia
- Myelodysplasia
- Unmanipulated Bone Marrow Graft with Tacrolimus/Methotrexate
- +5 more
-
Duarte, California
- +27 more
Nov 22, 2021
Renal Failure, Renal Insufficiency, Renal Disease Trial in Dresden (Advagraf)
Active, not recruiting
- Renal Failure
- +3 more
-
Dresden, GermanyUniversitätsklinikum Carl Gustav Carus
Aug 2, 2022
Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)
Completed
- Kidney Transplantation
- +2 more
-
London, United KingdomWest London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021
Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia (ALL) in Partial Remission
- +2 more
- Cyclophosphamide 50mg
- Methotrexate
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Center
Apr 4, 2022
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022
GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))
Recruiting
- Graft Versus Host Disease
- Cyclophosphamide
- anti-human T-lymphocyte immunoglobulin (ATLG)
-
Ramat Gan, IsraelChaim Sheba Medical Center
May 4, 2022
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021